Statistics for Vivoryon Therapeutics N.V. (id:79 VVY)

Valuation metrics

Market cap

53.44M

Enterprise value

37.65M

Trailing P/E (ttm)

Forward P/E

-2.71

PEG ratio

-2.71

Price/Sales (ttm)

-14.76

Price/Book (mrq)

3.79

Enterprise Value/Revenue

-10.40

Enterprise Value/EBITDA

-1.20

Overview

Shares outstanding

26.07M

Float

21.16M

Shares short

% Held by insiders

0.25%

% Held by institutions

0.14%

Average volume (10 days)

84.98K

Average volume (90 days)

Price summary

52-Week low

0.41

52-Week high

9.93

52-Week change

-282.80%

Beta

1.99

50-Day moving average

2.27

200-Day moving average

2.37

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

December 31th, 2023

Profitability

Profit margin

85.50%

Operating margin

866.13%

Operational effectiveness

Return on assets

-62.86%

Return on equity

-112.35%

Income statement

Revenue (ttm)

-0.14

Revenue per share (ttm)

-0.14

Quarterly revenue growth (yoy)

Gross profit (ttm)

-3,095,000.00

EBITDA

-31,265,000.00

Net income to common (ttm)

-31,185,000.00

Diluted EPS (ttm)

-1.20

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

15.27M

Total cash per share (mrq)

0.59

Total debt (mrq)

10.00K

Total Debt/Equity (mrq)

0.07

Current ratio (mrq)

937.30%

Book value per share (mrq)

0.54

Cash flow

Cash flow statement

-14,558,000.00

Levered free cash flow (LFCF)

-12,254,750.00